Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Sept 2009

Daniels Molly S, Urbauer Diana L, Stanley Jennifer L, Johnson Kristin G, Lu Karen H

Abstract excerpt

PURPOSE: To determine when, in reference to the course of their treatment, women with ovarian cancer are seen for genetic counseling, as well as to determine what factors influence this timing. METHODS: : Single institution retrospective chart review of patients with ovarian cancer who underwent BRCA1/BRCA2 genetic testing. RESULTS: Thirty-three percent of our sample (n = 100) were seen for genetic counseling...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 gene

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Neoplasm Recurrence, Local

Share to Ovarian Neoplasms

Share to Time Factors

Source

Identifiers

PMID: 19606053
DOI: 10.1097/GIM.0b013e3181ab2295

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer.PMID 19606053Read ↗

Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma.Semantic proximity Read ↗

Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancer.Semantic proximity Read ↗

Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.Semantic proximity Read ↗

Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 MutationsSemantic proximity Read ↗

Breast cancer after ovarian cancer in BRCA1 and BRCA2 pathogenic variant heterozygotes: Lower rates for 5 years post chemotherapy.Semantic proximity Read ↗

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.Semantic proximity Read ↗

Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care.Semantic proximity Read ↗

Improving referral for genetic risk assessment in ovarian cancer using an electronic medical record system.Semantic proximity Read ↗

Subsequent Oncology Visits Among Cancer Survivors Transitioned to Primary Care: A Retrospective Cohort StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.